The Limits of Limited Stage Lymphoma-Reference-Cited by-同舟云学术

The Limits of Limited Stage Lymphoma

Published:2004-08-01 Issue:15 Volume:22 Page:2982-2984
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Miller Thomas P.¹

Affiliation:

1. Arizona Cancer Center, University of Arizona, Tucson, AZ

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.05.926

Reference9 articles.

1. Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

2. Reyes F, Lepage E, Munck JN, et al: Superiority of chemotherapy alone with the ACVBP regimen over treatment with three cycles of CHOP plus radiotherapy in low risk localized aggressive lymphoma: The LNH93-1 GELA study. Blood 100:93a,2002, (abstr 343)

3. Brief Chemotherapy and Involved-Region Irradiation for Limited-Stage Diffuse Large-Cell Lymphoma: An 18-Year Experience From the British Columbia Cancer Agency

4. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL;Molecular Therapy - Oncolytics;2023-09

2. SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022);Clinical and Translational Oncology;2023-06-08

3. Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab;Advances in Radiation Oncology;2022-07

4. Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy;International Journal of Radiation Oncology*Biology*Physics;2022-07

5. Evolution of therapy for limited stage diffuse large B-cell lymphoma;Blood Cancer Journal;2022-02-24